Are Analysts Bullish about Tandem Diabetes Care, Inc. (NASDAQ:TNDM) after last week?

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Logo

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Ratings Coverage

Among 6 analysts covering Tandem Diabetes Care Inc (NASDAQ:TNDM), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Tandem Diabetes Care Inc had 10 analyst reports since February 14, 2019 according to SRatingsIntel. Lake Street maintained Tandem Diabetes Care, Inc. (NASDAQ:TNDM) rating on Wednesday, February 27. Lake Street has “Buy” rating and $100 target. Robert W. Baird maintained the stock with “Buy” rating in Thursday, March 7 report. On Friday, February 15 the stock rating was maintained by Robert W. Baird with “Buy”. The rating was maintained by Oppenheimer with “Buy” on Wednesday, February 27. As per Wednesday, February 27, the company rating was maintained by Piper Jaffray. As per Wednesday, February 27, the company rating was maintained by Cowen & Co. Below is a list of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) latest ratings and price target changes.

13/05/2019 Broker: Inc. – Common Stock Rating: Svb Leerink 83.0000
30/04/2019 Broker: Inc. – Common Stock Rating: Ubs New Target: $53.0000 66.0000
08/03/2019 Broker: BMO Capital Markets Rating: Outperform New Target: $77 Initiates Coverage On
07/03/2019 Broker: Robert W. Baird Rating: Buy New Target: $65 Maintain
27/02/2019 Broker: Lake Street Rating: Buy New Target: $100 Maintain
27/02/2019 Broker: Cowen & Co Rating: Buy New Target: $60 Maintain
27/02/2019 Broker: Piper Jaffray Rating: Buy New Target: $67 Maintain
27/02/2019 Broker: Oppenheimer Rating: Buy New Target: $68 Maintain
15/02/2019 Broker: Robert W. Baird Rating: Buy New Target: $55 Maintain
14/02/2019 Broker: Piper Jaffray Rating: Buy New Target: $60

The stock decreased 0.29% or $0.2 during the last trading session, reaching $68.97. About 657,758 shares traded. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has risen 1801.77% since May 31, 2018 and is uptrending. It has outperformed by 1797.40% the S&P500.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company has market cap of $4.01 billion. The companyÂ’s flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its disposable insulin cartridge, and an infusion set. It currently has negative earnings. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system.

More notable recent Tandem Diabetes Care, Inc. (NASDAQ:TNDM) news were published by: Fool.com which released: “Here’s What Caused Tandem Diabetes Stock to Gain a Jaw-Dropping 1,509% in 2018 – Motley Fool” on January 08, 2019, also Nasdaq.com with their article: “Why Tandem Diabetes Care Stock Sank Today – Nasdaq” published on April 17, 2019, Seekingalpha.com published: “Tandem Diabetes Care Q1 Earnings Preview – Seeking Alpha” on April 29, 2019. More interesting news about Tandem Diabetes Care, Inc. (NASDAQ:TNDM) were released by: Fool.com and their article: “3 Top Diabetes Stocks to Watch in April – The Motley Fool” published on April 13, 2019 as well as Nasdaq.com‘s news article titled: “Notable Wednesday Option Activity: TNDM, VRTX, LLY – Nasdaq” with publication date: April 17, 2019.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.